Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alexander Lazarev Insider Profile
4 Followers
Alexander Lazarev, Director at Pressure Biosciences, holds 18.54K shares in Pressure Biosciences (Ticker: PBIO).
Alexander Lazarev has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Alexander Lazarev's holdings
Insider Roles
Director
Roles that Alexander Lazarev holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Oct 07, 2011 - Oct 07, 2012
Return:-65.50%
The most profitable trade made by Alexander Lazarev
Alexander Lazarev's Trading History
List of latest transactions for each holding click on a transaction to see Alexander Lazarev's performance on stock
You May Also Like
Alexander Lazarev insider profile FAQ
What is the percentage of profitable transactions made by Alexander Lazarev?
The percentage of profitable transactions made by Alexander Lazarev is ―.
What is the average return per transaction made by Alexander Lazarev?
The average return per transaction made by Alexander Lazarev is ―.
What stocks does Alexander Lazarev hold?
Alexander Lazarev holds: PBIO stocks.
What was Alexander Lazarev’s latest transaction?
Alexander Lazarev latest transaction was an Uninformative Buy of $600.80.
What was Alexander Lazarev's most profitable transaction?
Alexander Lazarev’s most profitable transaction was an Informative Buy of PBIO stock on October 7, 2011. The return on the trade was -65.50%.
What is Alexander Lazarev's role in Pressure Biosciences?
Alexander Lazarev's role in Pressure Biosciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.